Stock Price
247.05
Daily Change
0.05 0.02%
Monthly
-19.70%
Yearly
-53.40%
Q1 Forecast
234.25

Novo Nordisk reported DKK542.9B in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Bausch Health Companies USD 26.37B 458M Dec/2025
Bristol-Myers Squibb USD 96.89B 2.21B Sep/2025
Eli Lilly USD 112.48B 2.46B Dec/2025
GlaxoSmithKline GBP 61.12B 221M Dec/2025
Merck USD 129.55B 12.02B Sep/2025
Novartis USD 107.29B 2.89B Sep/2025
Novo Nordisk DKK 542.9B 30.61B Dec/2025
Novo Nordisk DKK 76.18B 412.98B Jun/2025
Pacira USD 1.26B 32.66M Dec/2025
Sanofi EUR 126.81B 2.99B Dec/2025
Supernus Pharmaceuticals USD 1.45B 32.89M Dec/2025